Baptist Health Doc-to-Doc

How are molecular profiling, immunotherapy and new surgical approaches reshaping lung cancer treatment?

In this physician-focused conversation, thoracic medical oncologist Dr. Bruna Pellini and thoracic surgeon Dr. Ian Bostock discuss the clinical decisions that now drive personalized lung cancer care.

The discussion explores:

• Screening gaps and incidental pulmonary nodules
• Robotic bronchoscopy and mediastinal staging
• EGFR, ALK, PD-L1 and emerging biomarker-driven therapies
• Perioperative treatment sequencing and oligometastatic disease
• Robotic thoracic surgery, recovery and surgical quality measures

Learn why multidisciplinary evaluation and the order of treatment can be as important as the therapies themselves.

Host:
Bruna Pellini, M.D.
Chief of Thoracic Medical Oncology 
Herbert Wertheim Cancer Institute 

Ian Bostock, M.D.
Thoracic Surgeon
Herbert Wertheim Cancer Institute

If you found this episode helpful, we also recommend:

Early Lung Cancer Signs Most People Miss (Doctor Explains)

Lung Cancer Awareness Month: Vital Importance of Lung Cancer Screenings

Persistent tendinopathy can be difficult to treat, particularly when progressive loading and physical therapy aren’t enough.

In this Baptist Health Doc-to-Doc, Dr. Ronald Tolchin is joined by physical medicine and rehabilitation physician Dr. Raul Rosario-Concepcion and orthopedic surgeon Dr. William Davis to discuss how physicians can evaluate chronic tendon disease and determine when to escalate care.

They discuss:

- Tendinopathy vs. tendonitis and why the distinction matters
- Progressive loading as the foundation of treatment
- Where shockwave therapy, Tenex and PRP fit
- The benefits and risks of steroid injections
- How ultrasound and MRI guide treatment decisions
- When surgery becomes the right next step


From Achilles and rotator cuff disease to tennis elbow and plantar fasciopathy, the conversation explores how to match the right treatment to the right patient.

Host:
Ronald Tolchin, D.O.
Chair of Nonsurgical Spine Care & Rehabilitation 
Kalman Bass Endowed Chair in Pain & Rehabilitative Medicine 
Baptist Health Miami Neuroscience Institute

Guests:
Raul Rosario-Concepcion, M.D.
Physical Medicine & Rehabilitation
Baptist Health Miami Neuroscience Institute

William Davis, M.D. 
Orthopedic Surgeon 
Baptist Health Orthopedic Care

Complex vascular disease rarely follows a standard treatment strategy.

For patients with challenging anatomy, limited vascular access, significant comorbidities or complex aortic disease, traditional approaches may not be enough. Hybrid vascular procedures combine open surgery with minimally invasive endovascular techniques to expand treatment options and deliver more individualized care.

In this Baptist Health Doc-to-Doc discussion, Dr. Tom Nguyen is joined by vascular and endovascular surgeons Dr. Young Lee and Dr. Ignacio Rua to examine how hybrid approaches are changing clinical decision-making for complex vascular disease and helping physicians treat patients who previously had limited options.

Topics include:
• Open, endovascular and hybrid treatment options: How to choose the right approach
• Physiologic age vs. chronological age in treatment planning
• Multidisciplinary planning for complex aortic disease
• Advanced imaging, 3D reconstruction, image fusion and intravascular ultrasound (IVUS)
• Reducing contrast and radiation exposure in patients with renal disease
• Training the next generation of vascular specialists
• Robotics, artificial intelligence and emerging vascular technologies
• Research in venous valve replacement and limb preservation
• When early referral and second opinions create new treatment options

Learn more about Baptist Health Heart & Vascular Care and its comprehensive vascular services at BaptistHealth.net.

Experts:
Tom C. Nguyen, M.D. 
System Chief Executive, Baptist Health Heart & Vascular Care 
Chair and Professor, Cardiovascular Sciences, FIU

Young Lee, M.D. 
Vascular & Endovascular Surgeon 
Baptist Health Heart & Vascular Care

Ignacio Rua, M.D.
Vascular & Endovascular Surgeon
Baptist Health Heart & Vascular Care

If you found this episode helpful, you may also enjoy:

The New Arrhythmia Playbook-Hybrid Ablation, LAA Management & AI

AI the Quintessential Medical Tool?

Inappropriate Sinus Tachycardia - IST, What is it?

Epilepsy care has evolved dramatically in recent years. Advances in diagnostics, surgical techniques, and neuromodulation are transforming how physicians treat patients with drug-resistant epilepsy.

In this episode of Baptist Health Doc to Doc, Neurosurgeon and System Chief Executive of Baptist Health Brain & Spine Care and Chief Medical Executive of Miami Neuroscience Institute, Dr. Michael McDermott is joined by epilepsy experts, Dr. Aviva Abosch, deputy director of the Institute as well as director of epilepsy surgery and co-director of functional neurosurgery and Dr. Luis Tornes, neurologist and the director of the epilepsy program at the Miami Neuroscience Institute at Baptist Health South Florida.

Together they explore how multidisciplinary teams diagnose epilepsy, evaluate patients for surgery, and use advanced technologies such as responsive neurostimulation, deep brain stimulation, and stereotactic EEG to improve outcomes.

Topics include:
·         How physicians specialize in epilepsy care
·         The role of epilepsy monitoring units
·         Surgical approaches for drug-resistant epilepsy
·         Neuromodulation technologies like RNS, DBS, and VNS
·         Emerging therapies including biologics and cellular treatments

This conversation offers a deeper look at how neuroscience innovation is improving quality of life for patients living with epilepsy.

Learn more about the Epilepsy Program at Miami Neuroscience Institute: 

baptisthealth.net/neuroscience

Host:

Michael McDermott, M.D.
Neurosurgeon & Chief Medical Executive 
Baptist Health Miami Neuroscience Institute
Chair, Neurosciences, FIU

Guests:

Aviva Abosch, M.D.
Neurosurgeon & Deputy Director 
Baptist Health Miami Neuroscience Institute 

Luis Tornes, M.D. 
Neurologist & Director of the Epilepsy Program 
Baptist Health Miami Neuroscience Institute

If you found this episode helpful, you may also enjoy:

The Pituitary Playbook - Functional Tumors, Vision Risks & Endoscopic Solutions

Evolving Advances in Brain Tumor Care 

TMS: Making Waves with Treatment Resistant Depression

In this episode of Baptist Health Doc to Doc, Dr. John Diaz and Dr. Mehran Habibi discuss how artificial intelligence, robotic surgery, precision medicine, and targeted therapies are transforming breast cancer and gynecologic oncology in 2026.

Topics include:

- AI-assisted breast imaging and surgical planning
- Robotic hysterectomy and minimally invasive cancer surgery
- De-escalation of sentinel lymph node biopsy
- Circulating tumor DNA (MRD) and treatment personalization
- Antibody-drug conjugates (ADCs)
- Oral SERDs and evolving endocrine therapy
- HPV vaccination and cervical cancer prevention


As cancer care moves from radical procedures to optimized, personalized treatment, innovation is improving outcomes while reducing recovery time and surgical risk.

Presenters:

John P. Diaz, M.D., FACOG, FACS
Chief of Gynecologic Oncology
Baptist Health Miami Cancer Institute

Mehran Habibi, M.D., MBA
Deputy Chief of Breast Surgery
Baptist Health Cancer Care

Join Joseph Panoff, M.D., radiation oncologist at Baptist Health Miami Cancer Institute, and Youssef Zeidan, M.D., radiation oncologist at Lynn Cancer Institute, for an in-depth physician-to-physician discussion on modern breast cancer radiation therapy.

They explore how photon-based radiation has evolved over the last two decades—from early planning techniques to today’s highly conformal approaches that improve precision while reducing toxicity. The conversation also examines emerging comparisons between proton and photon therapy, including how each modality impacts cardiac exposure, skin toxicity, and long-term survivorship considerations.

This episode highlights the importance of individualized treatment planning, the growing focus on safely reducing unnecessary treatment, and how collaboration across leading cancer institutes is shaping the future of radiation oncology.

Host:
Joseph Panoff, M.D.  
Radiation Oncologist
Baptist Health Miami Cancer Institute

Guest:
Youssef Zeidan, M.D.  
Radiation Oncologist
Lynn Cancer Institute

In this episode of Baptist Health’s Doc-to-Doc, we take a closer look at one of the most concerning trends in oncology — the rise of breast cancer among younger women.

Dr. Anastasia Tousimis, Deputy Director of Baptist Health Cancer Care, sits down with Dr. Louise Morrell, Chief Medical Executive of Lynn Cancer Institute, to discuss what’s driving this gradual increase and how clinicians can better identify, screen and support high-risk patients.

Together, they explore the latest research on environmental and genetic factors, screening challenges in dense breasts and how AI is transforming early detection. The discussion also highlights fertility preservation and the importance of multidisciplinary care for young women navigating a diagnosis.

From radiation exposure to BRCA mutations, this conversation connects cutting-edge science with compassionate care — offering practical insight for clinicians and reassurance for patients alike.

Host:
Anastasia Tousimis, M.D.
Deputy Director, Baptist Health Cancer Care
Medical Director, Al and Jane Nahmad Women's Cancer Center, Baptist Health

Expert:
Louise Morrell, M.D.
Chief Medical Executive
Eugene M. & Christine E. Lynn Cancer Institute
Baptist Health Boca Raton Regional Hospital 

In this Baptist Health Doc-to-Doc episode, Dr. Michael McDermott, Chief Medical Executive of Baptist Health Miami Neuroscience Institute sits down with Dr. Evan Bander, Neurosurgeon & Co-Director of  the Pituitary Tumor Program at the Baptist Health Miami Neuroscience Institue, to unpack the complexities of the body’s “master gland.” 

Together, they explore how pituitary tumors are diagnosed and treated, the difference between functional and non-functional adenomas and why minimally invasive endoscopic surgery is changing outcomes. You’ll hear about early warning signs such as vision changes, the importance of a multidisciplinary pituitary team and the latest surgical and radiosurgical approaches. Whether you’re a clinician managing these conditions or a patient seeking to better understand them, this discussion sheds light on earlier detection, safer surgery and lifelong follow-up.

👉 If you are a neurosurgeon, endocrinologist, or ENT specialist managing pituitary disorders, this conversation will help sharpen your clinical edge.
👀 Patients and families can also learn what to look for and what today’s treatment options mean for long-term health.

🔔 Subscribe for more expert insights: @BaptistHealthSF

Host:

Michael McDermott, M.D.
Chief Medical Executive and Irma & Kalman Bass Endowed Chair in Clinical Neuroscience at Miami Neuroscience Institute, as well as Chair of the Department of Neurosciences at Florida International University Herbert Wertheim College of Medicine

Expert:

Evan Bander, M.D.
Neurosurgeon & Co-Director of the Pituitary Tumor Program
Baptist Health Miami Neuroscience Institute

In this episode of Baptist Health's Doc-to-Doc, we explore the evolving landscape of arrhythmia care with host Tom Nguyen, M.D., Chief Medical Executive of Baptist Health Heart & Vascular Care, Director of Minimally Invasive Surgery, and Barry T. Katzen Endowed Chair at Miami Cardiac & Vascular Institute, and Professor and Chair of the Department of Cardiovascular Sciences at Florida International University Herbert Wertheim College of Medicine. Electrophysiologist, Mario Pascual, M.D., and Cardiothoracic surgeon, Bryon Tompkins, M.D. of Baptist Health Heart & Vascular Care.

Together they discuss why early referral changes AFib outcomes, how hybrid epicardial-endocardial ablation strategies improve rhythm durability and the role of left atrial appendage management in reducing stroke risk. The conversation also highlights modern pacing approaches to protect heart function, the importance of timely device infection management and the emerging impact of Al and robotic mapping on electrophysiology and surgical collaboration.

👉 If you are a cardiologist, electrophysiologist or cardiac surgeon navigating the complexity of rhythm disorders, this conversation will help sharpen your clinical edge.

🔔 Subscribe for more expert insights: @BaptistHealthSF

Tom Nguyen, M.D.
Cardiac Surgeon & Chief Medical Executive
Baptist Health Heart & Vascular Care
Chair, Cardiovascular Sciences, FIU

Mario Pascual M.D.
Electrophysiologist
Baptist Health Heart & Vascular Care

Bryon Tompkins, M.D.
Cardiac Surgeon
Baptist Health Heart & Vascular Care

In this episode of Doc to Doc, we explore groundbreaking advances in the treatment of blood cancers with two of the field’s leading experts:
Dr. Guenther Koehne, Deputy Director and Chief of Blood and Marrow Transplant, Hematologic Oncology and Benign Hematology, and Dr. Firas El Chaer, Chief of Leukemia Services and Medical Director of Infusion — both from Baptist Health Miami Cancer Institute.

From precision-targeted therapies and measurable residual disease (MRD) to cutting-edge immunotherapies like (CAR) T-cell therapy, BiTEs, and NK-cell approaches — we cover the evolving tools that are reshaping treatment protocols across leukemia, myeloma, MDS, and lymphoma.

Topics Covered:
✅ MRD-guided treatment decisions
✅ Overcoming drug resistance with combination strategies
✅ Targeted therapies for actionable mutations
✅ The expanding role of CAR T, BiTEs, and NK cells
✅ Clinical application and access at Baptist Health

If you're an oncologist, hematologist, or transplant specialist navigating the complexity of hematologic malignancies — this conversation will help sharpen your clinical edge.

🔔 Subscribe for more expert insights: @BaptistHealthSF
📍 Learn more at MiamiCancerInstitute.com